Thioredoxin Reductase 1 inhibition triggers ferroptosis in KRAS-independent lung cancers
Cristina Andreani, Caterina Bartolacci, Margherita Melegari, Nicola Sargentoni, Lorenzo Luciani, Agnese Marucci, Roberta Galeazzi, Gina M. DeNicola, Jessica A. Kilgore, Noelle Sevilir Williams, Stefano Berto, Massimiliano Gaetani, Prasad Pattabhi, Sagid S. Osman, Ahmad T. Mansour, , Pier Paolo Scaglioni
The paper identifies TXNRD1 as a therapeutic target in KRAS-WT and KRASi-resistant lung cancers by showing TRXR1 inhibition induces ferroptosis through redox mechanisms.
bioRxiv · Jul 25, 2025 · PreprintCancer Biology